{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:39:54Z","timestamp":1770885594190,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bulcan.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T22:18:21Z","timestamp":1620339501000},"page":"S30-S38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["Prise en charge de la GVH digestive aigu\u00eb\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)"],"prefix":"10.1016","volume":"108","author":[{"given":"Eva","family":"de Berranger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Davy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dendonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9borah","family":"Desmier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Guenounou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"L\u2019hostette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Taque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Yafour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Seguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Yakoub Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bulcan.2021.01.013_bib0230","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrgastro.2017.126","article-title":"Acute graft-versus-host disease of the gut: considerations for the gastroenterologist","volume":"14","author":"Naymagon","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0235","first-page":"825","article-title":"1994\u00a0Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bulcan.2021.01.013_bib0240","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/01.TP.0000141092.08008.96","article-title":"Impact of small bowel exploration using video-capsule endoscopy in the management of acute gastrointestinal graft-versus-host disease","volume":"78","author":"Yakoub-Agha","year":"2004","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.bulcan.2021.01.013_bib0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MPG.0000000000000335","article-title":"Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation (HCT) in children","volume":"58","author":"Gosselin","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12659\/MSM.883755","article-title":"Serum citrulline levels as a marker of enterocyte function in patients after allogeneic hematopoietic stem cells transplantation\u00a0\u2013\u00a0a pilot study","volume":"19","author":"Vokurka","year":"2013","journal-title":"Med Sci Monit"},{"issue":"11","key":"10.1016\/j.bulcan.2021.01.013_bib0255","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.bbmt.2018.06.036","article-title":"Pretransplant serum citrulline predicts acute graft-versus-host disease","volume":"24","author":"Rashidi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2021.01.013_bib0260","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2017.03.005","article-title":"Citrulline and monocyte-derived macrophage reactivity before conditioning predict acute graft-versus-host disease","volume":"23","author":"Hueso","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2021.01.013_bib0265","doi-asserted-by":"crossref","first-page":"908e2","DOI":"10.1016\/j.cgh.2017.12.024","article-title":"Association between low plasma level of citrulline before allogeneic hematopoietic cell transplantation and severe gastrointestinal graft vs. host disease","volume":"16","author":"Hueso","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.013_bib0270","doi-asserted-by":"crossref","first-page":"1800897","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"issue":"11S","key":"10.1016\/j.bulcan.2021.01.013_bib0275","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.013_bib0280","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2141.2007.06797.x","article-title":"Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease","volume":"139","author":"Shimada","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.013_bib0285","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MPG.0000000000001776","article-title":"Choice of endoscopic procedure in children with clinically suspected gastrointestinal graft-versus-host disease","volume":"66","author":"M\u00e5rtensson","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.013_bib0290","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5152\/tjg.2016.15353","article-title":"Endoscopic evaluation of acute intestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"27","author":"Altun","year":"2016","journal-title":"Turk J Gastroenterol"},{"issue":"7","key":"10.1016\/j.bulcan.2021.01.013_bib0295","doi-asserted-by":"crossref","first-page":"e0200627","DOI":"10.1371\/journal.pone.0200627","article-title":"Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation. Palaniyandi S, \u00e9diteur","volume":"13","author":"Ohwada","year":"2018","journal-title":"Plos One"},{"issue":"11S","key":"10.1016\/j.bulcan.2021.01.013_bib0300","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.bulcan.2016.09.014","article-title":"Nutritional management for patients hospitalized during allogeneic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"103","author":"Bay","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.013_bib0305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1703352","article-title":"Weight loss and malnutrition in patients with chronic graft-versus-host disease","volume":"29","author":"Jacobsohn","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.013_bib0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bmt.2012.124","article-title":"Nutritional support in patients with GVHD of the digestive tract: state of the art","volume":"48","author":"van der Meij","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"12S","key":"10.1016\/j.bulcan.2021.01.013_bib0315","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.bulcan.2017.10.023","article-title":"Management of the chronic graft versus host disease: guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)","volume":"104","author":"Magro","year":"2017","journal-title":"Bull Cancer (Paris)"},{"issue":"7","key":"10.1016\/j.bulcan.2021.01.013_bib0320","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014\u00a0Ancillary therapy and supportive care working group report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.013_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","article-title":"Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease","volume":"17","author":"Wolff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.013_bib0330","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/1744666X.3.5.695","article-title":"Oral beclomethasone dipropionate in gastrointestinal graft-versus-host disease","volume":"3","author":"Hockenbery","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.bulcan.2021.01.013_bib0335","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.013_bib0340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.2007.06533.x","article-title":"Management of acute graft-versus-host disease","volume":"137","author":"Bacigalupo","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2019.07.017","article-title":"Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease","author":"Rashidi","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bulcan.2021.01.013_bib0350","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bbmt.2013.04.018","article-title":"Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis","volume":"19","author":"Jagasia","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.013_bib0355","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bulcan.2021.01.013_bib0360","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbmt.2019.03.003","article-title":"Changes in immunosuppressive treatment of chronic graft-versus-host disease: comparison of 2\u00a0surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland","volume":"25","author":"Wolff","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.013_bib0365","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/imt-2017-0156","article-title":"Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials","volume":"10","author":"Jagasia","year":"2018","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.013_bib0370","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbmt.2011.06.012","article-title":"Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment","volume":"18","author":"Xhaard","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0375","article-title":"A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor","author":"Xhaard","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.013_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/trf.14506","article-title":"Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?","volume":"58","author":"Worel","year":"2018","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.013_bib0385","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbmt.2018.11.017","article-title":"Etanercept as treatment of steroid-refractory acute graft-versus-host disease in pediatric patients","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.013_bib0390","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbmt.2013.01.018","article-title":"Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers","volume":"19","author":"Wolff","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.013_bib0395","first-page":"71","article-title":"The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease","volume":"68","author":"Alsuliman","year":"2020","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0400","unstructured":"Fredricks David N."},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.013_bib0405","doi-asserted-by":"crossref","first-page":"e1277307","DOI":"10.1080\/2162402X.2016.1277307","article-title":"Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: a multi-center prospective study","volume":"6","author":"Tan","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.013_bib0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbmt.2015.08.039","article-title":"Combination therapy with inolimomab and etanercept for severe steroid-refractory acute graft-versus-host disease","volume":"22","author":"van Groningen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.013_bib0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000496809","article-title":"Clinical use of mesenchymal stromal cells in the treatment of acute graft-versus-host disease","volume":"46","author":"Elgaz","year":"2019","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.013_bib0420","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","author":"Holler","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.013_bib0425","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/bbmt.2002.v8.pm11858189","article-title":"Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.013_bib0430","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/j.bbmt.2017.12.153","article-title":"Experience with the use of infliximab and\/or extracorporeal photopheresis in steroid-refractory acute graft versus host disease","volume":"24","author":"Nygaard","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2021.01.013_bib0435","unstructured":"Pentostatine pour le traitement de la GVH aigu\u00eb r\u00e9fractaire aux st\u00e9ro\u00efdes: analyse r\u00e9trospective monocentrique. https:\/\/fre.bioconus.com\/pentostatin-treatment-steroid-refractory-acute-gvhd-retrospective-single-center-analysis-307195."},{"key":"10.1016\/j.bulcan.2021.01.013_bib0440","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01459","article-title":"The gut microbiome as a major regulator of the gut-skin axis","volume":"9","author":"Salem","year":"2018","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.013_bib0445","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis. GEMINI 1\u00a0Study Group","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.013_bib0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14740338.2017.1300251","article-title":"The safety of vedolizumab for the treatment of ulcerative colitis","volume":"16","author":"Novak","year":"2017","journal-title":"Expert Opin Drug Saf"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:34:29Z","timestamp":1757792069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0007455121001181"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge de la GVH digestive aigu\u00eb\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}